Who makes Lactulose liquid 20 g?

Lactulose liquid 20 g is developed by Fresenius Kabi.

What development phase is Lactulose liquid 20 g in?

Lactulose liquid 20 g is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Lactulose liquid 20 g

Fresenius Kabi · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Lactulose liquid 20 g
Also known as	Laevolac liquid 20 g
Sponsor	Fresenius Kabi
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults (NA)
Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2 (PHASE4)
Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Lactulose liquid 20 g CI brief — competitive landscape report
Lactulose liquid 20 g updates RSS · CI watch RSS
Fresenius Kabi portfolio CI